ADMS
Adamas Pharmaceuticals
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
86 hedge funds and large institutions have $74.2M invested in Adamas Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
32% less capital invested
Capital invested by funds: $109M → $74.2M (-$34.8M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
86
Holding in Top 10
–
Calls
$656K
Puts
$581K
Top Buyers
| 1 | +$1.25M | |
| 2 | +$955K | |
| 3 | +$632K | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$593K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$549K |
Top Sellers
| 1 | -$11.1M | |
| 2 | -$3.44M | |
| 3 | -$2.73M | |
| 4 |
Millennium Management
New York
|
-$2.02M |
| 5 |
FI
Fosun International
Hong Kong,
China
|
-$1.33M |